International Assets Investment Management LLC Buys 738,701 Shares of Humana Inc. (NYSE:HUM)

International Assets Investment Management LLC increased its holdings in Humana Inc. (NYSE:HUM) by 261,025.1% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 738,984 shares of the insurance provider’s stock after purchasing an additional 738,701 shares during the period. International Assets Investment Management LLC’s holdings in Humana were worth $2,340,660,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Pzena Investment Management LLC boosted its holdings in Humana by 538.7% in the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after buying an additional 1,955,375 shares during the period. Davis Selected Advisers boosted its holdings in Humana by 16.1% in the 2nd quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider’s stock worth $863,640,000 after buying an additional 321,233 shares during the period. Marshall Wace LLP boosted its holdings in Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after buying an additional 774,085 shares during the period. Legal & General Group Plc boosted its holdings in Humana by 2.1% in the 2nd quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider’s stock worth $442,396,000 after buying an additional 24,842 shares during the period. Finally, Ontario Teachers Pension Plan Board boosted its holdings in Humana by 11,647.2% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock worth $367,342,000 after buying an additional 1,050,459 shares during the period. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. TD Cowen downgraded shares of Humana from a “buy” rating to a “hold” rating and cut their price objective for the stock from $402.00 to $261.00 in a report on Monday, October 7th. Oppenheimer lowered their target price on shares of Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research note on Thursday, October 3rd. Royal Bank of Canada lowered their target price on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Barclays lowered their target price on shares of Humana from $364.00 to $250.00 and set an “equal weight” rating on the stock in a research note on Thursday, October 10th. Finally, Piper Sandler cut shares of Humana from an “overweight” rating to a “neutral” rating and lowered their target price for the stock from $392.00 to $274.00 in a research note on Thursday, October 3rd. One equities research analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $315.33.

Humana Price Performance

Shares of NYSE:HUM opened at $258.61 on Thursday. The stock has a market cap of $31.16 billion, a PE ratio of 16.10, a PEG ratio of 1.91 and a beta of 0.50. The company’s fifty day moving average is $310.28 and its 200 day moving average is $337.43. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm’s revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the company earned $8.94 EPS. Research analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s payout ratio is presently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.